School of
Pharmacy and Pharmaceutical Sciences

Pharmaceutical Sciences (BS)

Upon completion of the program, students will be able to:

1. Demonstrate evidence-based knowledge of the scientific foundations of medication research, approval and development.
2. Apply scientific knowledge and principles of biological sciences, medicinal chemistry, pharmacology, pharmaceutics, pharmacokinetics, and pharmacogenomics to generate hypotheses, to design scientific experiments, to reliably execute experimental protocols, to statistically analyze and interpret scientific data, and to generate scientific
3. Apply quantitative principles in the calculations of doses, concentrations, molarities, standard curves and of pharmacokinetics.
4. Use communication and information technology effectively and
5. Retrieve, analyze, interpret, synthesize, and manage professional, lay, and scientific information and literature.
6. Collaborate and communicate with other members of an interdisciplinary laboratory research
7. Demonstrate effective written and verbal communication skills in order to present scientific
8. Accurately and safely prepare, store and use drugs and chemicals in accordance to applicable environmental health and safety
9. Demonstrate project management skills including project design, implementation, and
10. Demonstrate critical thinking and problem-solving
11. Exhibit ethical behavior and resolve dilemmas that arise in the research laboratory setting based on ethical principles of

Biomedical Science (MS)

The MS program learning outcomes are the following:

1. Students will have met the objectives for learning outcomes in an undergraduate discipline relevant to their graduate field of study.
2. Graduates will be able to summarize major themes and current research problems in their area of specialization.
3. Graduates will be able to communicate the major tenets of their field and their work orally and in writing for students, peers and the lay public.
4. Graduates will be able to identify areas where ethical issues may arise in their work or discipline, and articulate strategies for dealing with ethical issues in the profession.
5. Graduates will be able to explain and identify open problems and areas needing development in their fields.
6. Graduates will have carried out and presented an original work of research in their discipline, as applicable in Thesis bearing Master’s Program.

Pharmaceutical Science (MS)

The MS program learning outcomes are the following:

1. Students will have met the objectives for learning outcomes in an undergraduate discipline relevant to their graduate field of study.
2. Graduates will be able to summarize major themes and current research problems in their area of specialization.
3. Graduates will be able to communicate the major tenets of their field and their work orally and in writing for students, peers and the lay public.
4. Graduates will be able to identify areas where ethical issues may arise in their work or discipline, and articulate strategies for dealing with ethical issues in the profession.
5. Graduates will be able to explain and identify open problems and areas needing development in their fields.
6. Graduates will have carried out and presented an original work of research in their discipline, as applicable in Thesis bearing Master’s Program.

Pharmacology (MS)

The MS program learning outcomes are the following:

1. Students will have met the objectives for learning outcomes in an undergraduate discipline relevant to their graduate field of study.
2. Graduates will be able to summarize major themes and current research problems in their area of specialization.
3. Graduates will be able to communicate the major tenets of their field and their work orally and in writing for students, peers and the lay public.
4. Graduates will be able to identify areas where ethical issues may arise in their work or discipline, and articulate strategies for dealing with ethical issues in the profession.
5. Graduates will be able to explain and identify open problems and areas needing development in their fields.
6. Graduates will have carried out and presented an original work of research in their discipline, as applicable in Thesis bearing Master’s Program.

Biomedical Science (PhD)

The Doctor of Philosophy (PhD) program learning outcomes are the following:

1. Students will have met the objectives for learning outcomes in an undergraduate discipline relevant to their graduate field of study.
2. Graduates will be able to summarize major themes and current research problems in their area of specialization.
3. Graduates will be able to communicate the major tenets of their field and their work orally and in writing for students, peers and the lay public.
4. Graduates will be able to identify areas where ethical issues may arise in their work or discipline, and articulate strategies for dealing with ethical issues in the profession.
5. Graduates will be able to explain and identify open problems and areas needing development in their fields.
6. Graduates will have carried out and presented an original work of research in their discipline.

Pharmaceutical Science (PhD)

The Doctor of Philosophy (PhD) program learning outcomes are the following:

1. Students will have met the objectives for learning outcomes in an undergraduate discipline relevant to their graduate field of study.
2. Graduates will be able to summarize major themes and current research problems in their area of specialization.
3. Graduates will be able to communicate the major tenets of their field and their work orally and in writing for students, peers and the lay public.
4. Graduates will be able to identify areas where ethical issues may arise in their work or discipline, and articulate strategies for dealing with ethical issues in the profession.
5. Graduates will be able to explain and identify open problems and areas needing development in their fields.
6. Graduates will have carried out and presented an original work of research in their discipline.

Pharmacology (PhD)

The Doctor of Philosophy (PhD) program learning outcomes are the following:

1. Students will have met the objectives for learning outcomes in an undergraduate discipline relevant to their graduate field of study.
2. Graduates will be able to summarize major themes and current research problems in their area of specialization.
3. Graduates will be able to communicate the major tenets of their field and their work orally and in writing for students, peers and the lay public.
4. Graduates will be able to identify areas where ethical issues may arise in their work or discipline, and articulate strategies for dealing with ethical issues in the profession.
5. Graduates will be able to explain and identify open problems and areas needing development in their fields.
6. Graduates will have carried out and presented an original work of research in their discipline.

Doctor of Pharmacy (PharmD)

Outcomes — Sept ’23 onwards

Upon completion of the program, students will be able to:

1. Collect information necessary to identify a patient’s medication-related problems and health-related needs.
2. Assess collected information to determine a patient’s medication-related problems and health-related needs.
3. Create a care plan in collaboration with the patient, others trusted by the patient, and other health professionals to optimize pharmacologic and nonpharmacologic treatment.
4. Contribute patient specific medication-related expertise as part of an interprofessional care team.
5. Answer medication related questions using scientific literature.
6. Implement a care plan in collaboration with the patient, others trusted by the patient, and other health professionals.
7. Fulfill a medication order.
8. Educate the patient and others trusted by the patient regarding the appropriate use of a medication, device to administer a medication, or self-monitoring test.
9. Monitor and evaluate the safety and effectiveness of a care plan.
10. Report adverse drug events and/or medication errors in accordance with site specific procedures.
11. Deliver medication or health-related education to health professionals or the public.
12. Identify populations at risk for prevalent diseases and preventable adverse medication outcomes.
13. Perform the technical, administrative, and supporting operations of a pharmacy practice site.
14. Create a written plan for continuous professional development.

Outcomes — Through Spring ’26 (Legacy)

Ability based outcomes for the Doctor of Pharmacy Degree†

Domain 1 – Foundational Knowledge

1.1. Learner (Learner)

Develop, integrate, and apply knowledge from the foundational sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical sciences) to evaluate the scientific literature, explain drug action, solve therapeutic problems, and advance population health and patient— centered care.

Domain 2 – Essentials for Practice and Care

2.1. Patient—centered care (Caregiver)

Provide patient—centered care as the medication expert (collect and interpret evidence, prioritize, formulate assessments and recommendations, implement, monitor and adjust plans, and document activities).

2.2. Medication use systems management (Manager)

Manage patient healthcare needs using human, financial, technological, and physical resources to optimize the safety and efficacy of medication use systems.

2.3. Health andwellness (Promoter)

Design prevention, intervention, and educational strategies for individuals and communities to manage chronic disease and improve health and wellness.

2.4. Population—based care (Provider)

Describe how population—based care influences patient— centered care and influences the development of practice guidelines and evidence—based best practices.

Domain 3 — Approach to Practice and Care

3.1. Problem Solving (Problem Solver)

Identify problems; explore and prioritize potential strategies; and design, implement, and evaluate a viable solution.

3.2. Educator (Educator)

Educate all audiences by determining the most effective and enduring ways to impart information and assess understanding.

3.3. Patient Advocacy (Advocate)

Assure that patients’ best interests are represented.

3.4. Interprofessional collaboration (Collaborator)

Actively participate and engage as a healthcare team member by demonstrating mutual respect, understanding, and values to meet patient care needs.

3.5. Culturalsensitivity (Includer)

Recognize social determinants of health to diminish disparities and inequities in access to quality care.

3.6. Communication (Communicator)

Effectively communicate verbally and nonverbally when interacting with an individual, group, or organization.

Domain 4 – Personal and Professional Development

4.1. Self—awareness (Self—aware)

Examine and reflect on personal knowledge, skills, abilities, beliefs, biases, motivation, and emotions that could enhance or limit personal and professional growth.

4.2. Leadership (Leader)

Demonstrate responsibility for creating and achieving shared goals, regardless of position.

4.3. Innovation and Entrepreneurship (Innovator)

Engage in innovative activities by using creative thinking to envision better ways ofaccomplishing professional goals.

4.4. Professionalism (Professional)

Exhibit behaviors and values that are consistent with the trust given to the profession bypatients, other healthcare providers, and society.

† Adopted from Medina M, Plaza CM, Stowe CD, et al. Center for the Advancement of Pharmacy Education 2013 Educational Outcomes. Am J Pharm Ed. 2013;77(8):162.
Approved, 2013